secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vericel Corp (VCEL)
CIK:        0000887359
Form:       8-K
Filed at:   2022-01-12T23:59:59+00:00
Accession:  0001104659-22-003394
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vericel estimates FY2021 revenue growth 25-26%, adj. EBITDA ~$30M, cash ~$129M
------------------------------------------------------------------------------

- Preliminary FY2021 revenue growth of 25%-26% (unaudited); total adjusted EBITDA ~$30M.
- Cash and investments as of Dec 31, 2021 ~$129M.
- Company presented at 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022.
- Financial results are preliminary and subject to change upon audit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887359/000110465922003394/0001104659-22-003394-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887359/000110465922003394/tm222643d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-003394

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer